Novotech Publishes Research Report on Acute Myeloid
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data...
Stay updated with breaking news from Opna Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data...
FogPharma is preclinical, but not for long. The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
By using the patient's own immune system against the tumour, immunotherapy is a cutting-edge method of treating cancer